FDA official discusses common deficiencies derailing ANDAs
Regulatory NewsJoanne S. Eglovitch
ComplianceHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy